CVS

NYSE

CVS HEALTH Corp

Health Care, Health Care Services

$95.70

close 7 Aug 2026

+47.50%

52-week change

$122.30B

market cap

$64.32

$110.68

52-week range

Valuation

Market cap$122.30B

P/E (TTM / 5y avg)25.25x33.78x

Forward P/E (FY2026 / FY2027)12.37x11.30x

PEG (TTM / fwd)—1.32

P/S (TTM)0.29x

P/B1.53x

EV/EBITDA (TTM)13.46x

FCF yield (TTM)9.61%

Cash flow & dividend

FCF (TTM)$11.76B

FCF per share (TTM)$9.20

FCF margin (TTM)2.83%

Dividend yield (indicated / 5y avg)2.78%3.30%

Annualized dividend$2.66

Payout ratio (EPS / FCF)69.70%29.05%

Growth & quality

Revenue YoY, latest Q+7.26%

Diluted EPS YoY, latest Q+188.75%

Operating margin (TTM)2.00%

Net margin (TTM)1.18%

ROE (latest FY)2.35%

Net debt / EBITDA (TTM)3.91

Interest coverage (TTM)2.67

Price

+13.44%+2.56%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +8.39%10Y CAGR +10.12%

Diluted EPS

5Y CAGR -23.94%10Y CAGR -11.34%

FCF per share

5Y CAGR -9.68%10Y CAGR +1.18%

Operating cash flow

5Y CAGR -7.68%10Y CAGR +2.22%

Free cash flow

5Y CAGR -10.28%10Y CAGR +2.38%

Dividends per share

5Y CAGR +6%10Y CAGR +6.72%

Payout ratio

FCF payout ratio

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -0.60%10Y CAGR +1.45%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date27 Oct 2026bmo

EPS estimate$1.73

Revenue estimate$104.28B

Last reported

Date—

EPS——

Revenue——